WM-A1-3389

Other Medications

EU Experimental ES Not available 1 Clinical Trials

Description

WM-A1-3389 is an investigational medication currently being studied by Wellmarker Bio. It is being tested in clinical trials, including one for people with advanced colorectal cancer. This trial is in Phase 1, which means it is primarily focused on determining the safety and appropriate dosage of the drug. The trial involves giving WM-A1-3389 in combination with pembrolizumab (Keytruda), a type of immunotherapy already used for some cancers. The study is looking at people whose tumors express PD-L1. WM-A1-3389 is not yet approved for treating colorectal cancer or any other condition.

Mechanism of Action

WM-A1-3389 is being investigated as a potential treatment for cancer. The specific way it works (its mechanism of action) is still being studied in clinical trials. It is being tested in combination with pembrolizumab, an immunotherapy drug that helps the body's immune system fight cancer. The combination is being evaluated for its potential effects on tumor growth and response.

Side Effects

Because WM-A1-3389 is an investigational drug in early-phase trials (Phase 1) The full range of potential side effects is still being evaluated. The primary goal of Phase 1 trials is to assess safety. Information about specific side effects observed in the ongoing trials is not yet widely available. Participants in the trial will be closely monitored for any adverse events.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT05872867 Phase 1
Unknown
Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90)
South Korea

Quick Info

CategoryOther Medications
EU EMA StatusExperimental
ES Spain AccessNot available
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
771 trials
Leucovorin
Other Medications
631 trials
Trifluridine
Other Medications
45 trials
Paclitaxel
Other Medications
43 trials
Cyclophosphamid
Other Medications
40 trials
Cyclophosphamide
Other Medications
39 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.